Summary
For Year 2026-27, RJ Bio-Tech reports the following shareholding: Total Promoters at 60.32%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 39.68%. This breakdown provides a quick snapshot of ownership distribution for RJ Bio-Tech in 2026-27.
RJ Bio-Tech FAQs
As of 04-2026, the promoter shareholding in RJ Bio-Tech stands at 60.32% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of RJ Bio-Tech is 0% and 0% respectively.
The retail shareholding of the RJ Bio-Tech is 39.68%.
Changes in shareholding patterns of RJ Bio-Tech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of RJ Bio-Tech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
